NEW YORK (GenomeWeb News) – Spain's Institute of Molecular and Medical Genetics, or INGEMM, has purchased a CapitalBio Array Platform through the distributor Biotools, Biotools said today.

The Madrid-based INGEMM, located at the La Paz University Hospital, will also receive continuous training and advice from Biotools in the use of the platform and in the design of microarray experiments.

The company said the agreement is the beginning of "a close collaboration with INGEMM aimed at developing microarrays for pharmacogenomics and genetic disease diagnostics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.